Centene Corp. stock stays above USD 60 after earnings beat

Published on 09/25/2026 at 14:30 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Centene Corp. stock carries a USD 70.05 average analyst target dated September 25, 2026. Q2 premium and service revenue reached USD 44.4 billion, while adjusted EPS came to USD 2.51.

Modernes Gesundheitszentrum-Gebäude mit Patienten am Eingang, Außenaufnahme, Tageslicht — Centene Corp. betreibt moderne ambulante Gesundheitszentren in den USA, ISIN US15133V1035 an der NYSE, Illustration mit AI erstellt.

Centene Corp. (ISIN US15133V1035) stock was trading at USD 61.91 on the NYSE on September 24, 2026, down 0.27 percent from the prior close of USD 62.08. The latest analyst snapshot dated September 25, 2026, put the average 12-month price target at USD 70.05 and the consensus rating at Hold, according to MarketBeat.

Q2 earnings reset the baseline

Centene reported Q2 2026 total revenue of USD 53.579 billion, GAAP diluted EPS of USD 2.19 and adjusted diluted EPS of USD 2.51 in its July 27 filing, according to StockTitan. Quarterly revenue rose 9.9 percent year over year, while the filing also reported a consolidated health benefits ratio of 89.6 percent versus 93.0 percent in the comparable period.

Fortune reported that premium and service revenue reached USD 44.4 billion and that adjusted diluted EPS of USD 2.51 exceeded the company's previous expectations. Operating cash flow was USD 3.6 billion in Q2 2026, giving the earnings beat a cash-generation component.

Guidance now points higher

Centene's 2026 guidance calls for total revenue of USD 193.5 billion to USD 197.5 billion, USD 173.0 billion to USD 177.0 billion in premium and service revenue, GAAP diluted EPS greater than USD 3.11 and adjusted diluted EPS greater than USD 4.80, according to StockTitan.

The adjusted EPS floor is higher than the prior outlook of greater than USD 3.40 disclosed on the earnings call, while the revenue guidance increased by USD 6.0 billion. Fortune said the updated adjusted EPS outlook includes USD 0.50 from settlements of 2025 items that are not expected to recur in 2027.

Analyst target stays above the quote

The USD 70.05 average target stands 13.15 percent above the NYSE price of USD 61.91 on September 24, 2026. MarketBeat listed targets from USD 69 to USD 80 and counted 9 Buy, 9 Hold, 2 Sell and 1 Strong Buy rating among 21 brokerages on September 25, 2026.

Barclays reaffirmed an Overweight rating and lifted its price objective from USD 75.00 to USD 80.00 on July 29, 2026, according to MarketBeat. The spread between the USD 61.91 quote and the analyst range shows that the market is still pricing the stock below the prevailing target band.

Stock holds above USD 60

Centene stock traded between USD 61.25 and USD 62.84 during the September 24 session, with volume of 4,357,581 shares. Its 52-week range was USD 31.63 to USD 69.63, and its market capitalization stood at USD 30,583,230,450.

The reference quote was USD 61.91 on the NYSE on September 24, 2026 at 3:59 p.m. ET, down 0.27 percent from USD 62.08. For investors, the central valuation question is whether the higher 2026 guidance can offset the one-time contribution identified in the Q2 outlook.